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Physiotherapists’ use of airway clearance
techniques during an acute exacerbation of
bronchiectasis: a survey study
Jennifer Phillips1,2* , Annemarie Lee3,4,5, Rodney Pope6 and Wayne Hing1
Abstract
Background: Airway clearance techniques are recommended for individuals with bronchiectasis both in stable
state and during an acute exacerbation, however the current use of airway clearance techniques in the
management of individuals during an acute exacerbation is unclear. The aims of this study were to establish what
current physiotherapy clinical practice comprises for adults and paediatrics during an acute exacerbation of
bronchiectasis; identify physiotherapist’s perceptions of the effectiveness of airway clearance techniques and
identify what factors influence their treatment decisions in this population.
Methods: An anonymous online survey was distributed to the members of the Australian Physiotherapy
Association and Physiotherapy New Zealand between August 2016 and April 2017.
Results: The survey was accessed by 130 physiotherapists and 121 of those deemed themselves eligible and
consented to participate. Most participants (89%) reported prescribing airway clearance techniques for 81–100% of
individuals during an acute exacerbation of bronchiectasis. The most commonly used airway clearance techniques
with adults were huffing (92%), exercise (89%) and the active cycle of breathing technique (89%). The techniques
perceived most effective for adults were physical exercise (100%), oscillating positive expiratory pressure devices
(97%), directed huffing (95%) the active cycle of breathing technique (90%) and positive expiratory pressure (90%).
The most commonly used airway clearance techniques for paediatric patients were: newborn-3 years - percussion
(85%) and modified postural drainage (85%); 4–10 years - huffing (100%) and exercise (85%); 11–18 years - huffing
(92%) and exercise (77%), active cycle of breathing technique (77%) and positive expiratory pressure therapy (77%).
The techniques perceived most effective for paediatric patients were directed huffing (100%), percussion (100%)
and positive expiratory pressure via a mask or mouthpiece (93%). The most commonly reported factors influencing
choice of technique were patient clinical presentation (72%) and the presence/absence of contra-indications (72%).
Conclusion: This survey demonstrates that airway clearance techniques are routinely used as part of physiotherapy
management of individuals experiencing an acute exacerbation of bronchiectasis, and that choice of technique and
perceived effectiveness varies depending on the age of the patient.
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Introduction
Bronchiectasis is a chronic lung condition characterised
by repeated respiratory infections, productive cough,
shortness of breath and decreased exercise tolerance
[1, 2]. Management involves medication and physiotherapy,
aiming to improve airway clearance and exercise tolerance,
minimise exacerbations and improve health-related quality
of life (HRQOL) [3–5]. Physiotherapy involvement in the
management of bronchiectasis is supported by international
guidelines which state that individuals with a chronic
productive cough or difficulty clearing sputum should be
taught an airway clearance technique (ACT) by a trained
respiratory physiotherapist [4, 6–8]. During an acute
exacerbation of bronchiectasis, intensive ACTs, including
altered prescription and follow-up, are required [4].
Airway clearance techniques consist of a variety of
breathing patterns with or without a device, designed to
aid sputum clearance, improve ventilation and reduce
cough frequency [9, 10]. Techniques include the active
cycle of breathing technique (ACBT), autogenic drainage,
postural drainage (PD), manual techniques, positive ex-
piratory pressure (PEP) and oscillating PEP devices [5, 11].
Although guidelines recommend the use of ACTs, it is
unclear which ACT is most effective during an acute
exacerbation of bronchiectasis, and how often and for
how long each technique should be implemented [12, 13].
To guide clinically relevant future research investigat-
ing the clinical efficacy of ACTs that are commonly
used, it is important to know the current management
of individuals with bronchiectasis. Three survey studies
have investigated physiotherapists’ use of ACTs in bron-
chiectasis [11, 14, 15]. However, they did not focus on
management of individuals with an acute exacerbation,
and new guidelines for the management of individuals
with bronchiectasis have subsequently been published in
Australia, Brazil, Britain, and Europe [4, 6–8].
The aims of this study were to: (1) establish what current
physiotherapy clinical practice in Australia and New Zealand
comprises for adults and paediatrics during an acute exacer-
bation of bronchiectasis; (2) identify physiotherapist’s percep-
tions of the effectiveness of ACTs and (3) identify what
factors influence their treatment decisions in this population.
Methods
Study design
A cross-sectional, online, survey was carried out between
August 2016 and April 2017 using the Qualtrics plat-
form (Qualtrics, Provo Utah, USA). Ethical approval
was received for this research, and informed consent
provided by all participants.
Participants
Therapists were eligible to participate in the study if they
were a physiotherapist who currently and routinely (in
the last 12 months) treated adult or paediatric individ-
uals during an acute exacerbation of bronchiectasis as
inpatients or outpatients. The following definition of an
acute exacerbation was provided to participants at the
start of the survey: An acute exacerbation of bronchiectasis
involves a sudden change in symptoms such as increased
cough, change in sputum (volume, colour, viscosity),
breathlessness, haemoptysis and/or constitutional upset
(malaise, tiredness) [5].
Physiotherapists were recruited through newsletters of
the professional bodies (the Australian Physiotherapy
Association and Physiotherapy New Zealand), which
included a link to the online survey. The electronic link
took the physiotherapist to an information and consent
page, and if the physiotherapist deemed themselves
eligible and consented to participate, they clicked a
button to proceed to the survey. The survey invitation
was disseminated on four occasions, to maximise responses.
Participant responses were anonymous.
Survey design
A team of four physiotherapists developed the survey
following a literature review, using a combination of new
questions and questions from previous surveys investi-
gating physiotherapy management of respiratory condi-
tions [11, 15, 16]. The research team involved two
experienced clinicians in respiratory physiotherapy, and
two researchers with previous work in quantitative and
qualitative research. The survey was tested for content
and construct validity throughout the development
process by the research team, and prior to distribution
was piloted in an independent group of six experienced
respiratory physiotherapists. No changes were made to
the survey following the pilot, prior to distribution.
All participants were asked three questions collecting
their personal demographic information. They were
subsequently directed to complete additional relevant
sections based on the management of adults, paediatrics,
or both. Questions regarding use of ACTs in the paedi-
atric population were split into age groups (newborn-3
years, 4–10 years and 11–18 years) due to expected
differences in clinical management based on age [17].
The survey was divided into domains: (1) workplace
demographics, (2) ACTs used and perceived effective-
ness (3) participants’ rationales for treatment decisions
regarding use of ACTs.
The workplace demographic domain (domain 1) con-
tained six multiple choice questions and participants
were able to select one response. Information regarding
inpatient and outpatient settings was collected in rela-
tion to ACT prescription frequency only, and no other
comparison of clinical practice in each setting was
collected. Participants were asked a multiple-choice
question to determine what percentage of patients with
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an exacerbation of bronchiectasis to whom they pre-
scribed ACTs, with the options including “81-100%, 61-
80%, 41-60%, 21-40% or 0-20%”. The domain for ACTs
used (domain 2) contained three questions. These ques-
tions gathered information regarding the use of different
types of ACTs and were predominantly designed as
four- or five-point Likert scales (e.g. routinely, occasion-
ally, rarely or never) to allow for comparison to previous
studies. Content (such as ACTs listed) was based on pre-
vious surveys, clinical practice guidelines and research,
[11, 15, 16], with an open, ‘other’, option to capture
information from participants who used ACTs that were
not listed. Multiple choice questions were also used to
gather information regarding prescription of ACTs. The
questions relating to rationales for treatment decisions
(domain 3) used a combination of Likert scales, multiple
choice questions with single or multiple responses
allowed, and open-ended questions. Perceived effective-
ness of each airway clearance technique was investigated
using a Likert scale from very effective, effective, neutral,
ineffective or very ineffective following the question “how
effective at clearing sputum do you believe the following
ACTs are for patients with an acute exacerbation of bron-
chiectasis”. In total, the survey included 29 questions
regarding the management of adults, and 30 questions
regarding paediatric management. The final version of the
survey can be obtained from the authors upon request.
Statistical analysis
Data were analysed descriptively using SPSS V.25 (SPSS,
Chicago, Illinois, USA) and presented using tables and
narrative text. Results were presented as frequencies and
percentages of participants who responded to that question.
Results
Survey response
The survey was distributed widely to approximately 26,
000 email addresses (Australian Physiotherapy Associ-
ation membership = 23,153, Physiotherapy New
Zealand membership = 3596) [18, 19]. The survey was
accessed by 130 individuals between August 2016 and
April 2017, and 121 of those identified themselves as
eligible physiotherapists and consented to participate.
Two people accessing the survey declined to consent
and seven had not treated an adult or child with an
acute exacerbation of bronchiectasis in the last 12
months, and were therefore ineligible and excluded.
Sixty-two participants (51%) partly completed the
survey, and their completed responses were included
in the analysis along with responses from participants
who completed the survey in its entirety. As the num-
ber of responses per question was variable, the tables
included in the manuscript each state the total number
of participants responding to each question.
Participant demographics
Eligible participants were from both Australia (n = 106;
88%) and New Zealand (n = 12; 10%) and three partici-
pants accessed the survey from other countries (Table 1).
All states in Australia and both islands in New Zealand
were represented. Participants ranged in experience in
respiratory physiotherapy (Table 2). Most participants
(68%) managed only adults with an acute exacerbation
of bronchiectasis, and so completed the adult section of
the survey; 15% had managed only children and so
completed the paediatric section of the survey, and
11% completed both sections.
Airway clearance prescription
Most participants (86%) working with adults and all
participants (100%) working in paediatrics reported they
prescribed ACTs in 81 to 100% of instances in which they
contributed to management of an acute exacerbation of
bronchiectasis. In inpatient settings, adult inpatients were
most commonly treated once or twice per day (once per
day 52%, twice per day 47%, three times per day 1%). In
paediatric settings, inpatients were most commonly
treated twice per day (once per day 5%, twice per day 86%,
three times per day 9%). In outpatient settings, both adults
and paediatric patients were most commonly treated once
per fortnight (45 and 65% respectively), followed by once
per week (28 and 20% respectively). Time spent on ACT
per therapy session in an adult population was most com-
monly 11–15min (34%), followed by 16–20min (31%)
and 21 or more min (27%). Time spent on ACT in each
session was longer in a paediatric population, most com-
monly 16–20min (58%), followed by 21min or more
(36%) then 11–15min (6%).
Table 1 Participant locations (n (%); N = 121)
Location Participants n (%)
Australia
Australian Capital Territory 1 (1)
New South Wales 22 (18)
Northern Territory 2 (2)
Queensland 59 (49)
South Australia 4 (3)
Tasmania 4 (3)
Victoria 7 (6)
Western Australia 7 (6)
New Zealand
North Island 11 (9)
South Island 1 (1)
Other 3 (2)
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Airway clearance techniques used
The most commonly used ACTs with adults were
directed huffing (92%), physical exercise (89%) and the
ACBT (89%) (Table 3). Positioning (84%) and oscillating
PEP devices (75%) were also used regularly. Within
paediatric populations, the most commonly used ACT
varied depending on age group. In the newborn-three
years age group, the most commonly reported ACTs
were modified PD (no head down tilt) (85%), percussion
(84%) and positioning (72%) (Table 3). In the 4–10 years
age group, participants reported most commonly using
directed huffing (100%), physical exercise (85%) and PEP
mask or mouthpiece (75%) (Table 3). In the 11–18 years
age group participants reported most commonly using
directed huffing (93%), the ACBT (77%), PEP mouthpiece
or mask (77%) and physical exercise (77%) (Table 3).
Perceived effectiveness of ACTs
Participants working with adults perceived the most
effective techniques were physical exercise (100%), oscillat-
ing PEP devices (97%), directed huffing (95%), the ACBT
(90%) and PEP mask or mouthpiece (90%) (Table 4). All
participants believed that physical exercise, PEP therapy,
directed huffing and oscillating PEP devices were effective
(Table 4). The ACTs considered least effective in adults
were PD including head down tilt (23%), sustained maximal
inspiration (18%) and mechanical vibration (18%).
In paediatrics, the techniques considered most effective
were directed huffing (FET) (100%), PEP mask or mouth-
piece (93%) and percussion (100%) (Table 4). The ACTs
considered least effective were PD including head down
tilt (54%) and mechanical vibration (14%).
Factors influencing treatment decisions
The most commonly reported “extremely important fac-
tors” in choosing ACTs were ‘patient clinical presentation’
(72%) and ‘the presence/absence of contra-indications’
(72%) (Table 5). Factors most frequently considered “not
at all important” were ‘taught at university’ (46%) and
‘medical staff’s preference’ (25%).
Most participants (71%) stated they were aware of the
clinical guidelines [4] for bronchiectasis in children and
adults in Australia and New Zealand. Regarding whether
a change in practice at their place of work had occurred
following guideline publication [4], 51% reported no
change in practice, 31% were unsure if change occurred
and 18% of participants reported a practice change.
Reported changes in practice indicated via free text
response included caution with the use of inhaled
corticosteroids, greater use of autogenic drainage,
more focus on hydration, increased confidence using
prescribed exercise as part of ACT and increased
medical acknowledgement of the role of physiotherapy
and ACTs in management. Participants also reported
that they were now less likely to trial nebulised
hypertonic saline and felt that the guidelines rein-
forced the concept that tailoring ACTs to individual
needs is appropriate.
Regarding knowledge of scientific evidence available
for ACTs in this population, 23% of participants working
with adults reported they were unsure what the current
evidence indicated. In contrast, no participants working
in the paediatric setting reported uncertainty regarding
current evidence.
Discussion
This survey is the first to investigate the current practice
of physiotherapy with respect to use of ACTs for indi-
viduals experiencing an acute exacerbation of bronchiec-
tasis. The most commonly used ACT varied depending
on the age of the individual with bronchiectasis, how-
ever, directed huffing, physical exercise, the ACBT and
PEP therapy were frequently used across most age
groups, while modified postural drainage and percussion
were most commonly applied in patients aged newborn-
3 years. Participants perceived physical exercise, oscillat-
ing PEP therapy, directed huffing and the ACBT to be
the ACTs most effective when working with adults,
while directed huffing, PEP therapy and percussion
were most effective when working with children. The
important factors for choice of technique were patient
presentation, and the presence/absence of contra-
indications/precautions.
Most participants prescribed ACTs to their patients
with an acute exacerbation of bronchiectasis, but the
frequency and duration of intervention varied between
adult and paediatric inpatients. This difference may be
attributed to the greater ease with which adults can be
taught an ACT and undertake this independently, while
children require more supervision. It has been recom-
mended that individuals admitted with an exacerbation
of bronchiectasis are seen daily until their airway clear-
ance is optimised, and that the duration is a minimum
of 10min and maximum of 30min or until the patient
becomes fatigued [6]. Participants adhered to guideline
recommendations, with participants working with adults
Table 2 Participant years of practice (n (%); N= 120)
0–5 years 6–10 years 11–15 years 16–20 years 21 years or more
Years as a physiotherapist 33 (28%) 21 (17%) 20 (16%) 15 (13%) 31 (26%)
Years practicing in respiratory physiotherapy 48 (40%) 24 (20%) 22 (18%) 5 (4%) 21 (18%)
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Table 3 Frequency of use of ACTs (n (%); N physiotherapists treating adults = 64; N physiotherapists treating paediatrics = 13)
Airway clearance technique Very often/always or often Sometimes Rarely/never
Active Cycle of Breathing Technique
Newborn – 3 yrs 1 (8) 1 (8) 11 (84)
4–10 years 8 (67) 2 (17) 2 (16)
11–18 years 10 (77) 1 (8) 2 (16)
Adult 57 (89) 3 (5) 4 (6)
Autogenic Drainage
Newborn – 3 yrs 2 (16) 2 (17) 8 (67)
4–10 years 1 (8) 5 (38) 7 (54)
11–18 years 5 (39) 5 (39) 3 (23)
Adult 20 (31) 17 (27) 27 (42)
Deep breathing exercises
Newborn – 3 yrs 4 (39) 2 (15) 6 (46)
4–10 years 9 (70) 1 (8) 3 (23)
11–18 years 7 (54) 3 (23) 3 (23)
Adult 41 (65) 12 (19) 10 (16)
Directed huffing (Forced Expiration Technique)
Newborn – 3 yrs 5 (46) 2 (16) 5 (39)
4–10 years 13 (100) 0 (0) 0 (0)
11–18 years 12 (93) 0 (0) 1 (7)
Adult 59 (92) 5 (8) 0 (0)
Postural Drainage (Head Down Tilt)
Newborn – 3 yrs 1 (8) 1 (8) 11 (85)
4–10 years 1 (8) 1 (8) 11 (85)
11–18 years 0 (0) 2 (15) 11 (85)
Adult 5 (8) 12 (19) 46 (73)
Modified Postural Drainage (no Head Down Tilt)
Newborn – 3 yrs 11 (85) 1 (8) 1 (8)
4–10 years 6 (46) 4 (31) 3 (23)
11–18 years 3 (23) 2 (15) 8 (62)
Adult 30 (47) 17 (26) 17 (26)
Manual vibration
Newborn – 3 yrs 7 (54) 4 (31) 2 (16)
4–10 years 8 (62) 3 (23) 2 (16)
11–18 years 4 (31) 3 (23) 6 (46)
Adult 30 (47) 18 (28) 16 (25)
Mechanical vibration (Vest)
Newborn – 3 yrs 0 (0) 0 (0) 12 (100)
4–10 years 0 (0) 0 (0) 13 (100)
11–18 years 0 (0) 0 (0) 13 (100)
Adult 5 (8) 0 (0) 58 (92)
Oscillating Positive Expiratory Pressure device
Newborn – 3 yrs 0 (0) 0 (0) 12 (100)
4–10 years 6 (46) 2 (23) 4 (31)
11–18 years 7 (54) 1 (8) 5 (39)
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reporting the provision of one or two sessions per day,
most commonly of 11–15 min duration, while most
paediatric physiotherapists treated individuals twice
daily, most commonly for 16–20min. This is similar to a
previous survey, which reported most child participants
with bronchiectasis completed airway clearance therapy
at least once per day when unwell [14].
The most commonly implemented ACTs in an adult
population were the ACBT, directed huffing and phys-
ical exercise, similar to previous surveys in bronchiec-
tasis [11, 15]. Additionally, all three techniques were
perceived effective by more than 90% of participants.
However, there is little evidence available for the use of
the ACBT or physical exercise in individuals with exac-
erbations of bronchiectasis [13]. The ACBT and huffing
are commonly used ACTs clinically as they require no
equipment, can be completed in a range of positions and
can be adapted to the patient and their presenting con-
dition [20]. The ACBT has been investigated in one
study with individuals with an exacerbation of bronchi-
ectasis, and was found to be superior in sputum expec-
toration (greater decrease in 24 h collection), cough-
related quality of life and gas exchange when compared
to more traditional ACTs of percussion and postural
drainage [21]. Physical exercise as an ACT has not been
investigated in individuals with an exacerbation of
Table 3 Frequency of use of ACTs (n (%); N physiotherapists treating adults = 64; N physiotherapists treating paediatrics = 13)
(Continued)
Airway clearance technique Very often/always or often Sometimes Rarely/never
Adult 48 (75) 12 (19) 4 (6)
Oscillating Positive Expiratory Pressure bubble/bottle
Newborn – 3 yrs 6 (47) 1 (8) 6 (47)
4–10 years 9 (69) 1 (8) 3 (23)
11–18 years 7 (54) 1 (8) 5 (39)
Adult 41 (65) 8 (13) 14 (22)
Positive Expiratory Pressure mask or mouthpiece
Newborn – 3 yrs 4 (32) 5 (37) 4 (31)
4–10 years 9 (75) 1 (8) 2 (16)
11–18 years 10 (77) 1 (8) 2 (16)
Adult 26 (41) 21 (33) 16 (26)
Percussion
Newborn – 3 yrs 11 (84) 1 (8) 1 (8)
4–10 years 6 (47) 4 (31) 3 (23)
11–18 years 3 (23) 4 (31) 6 (46)
Adult 24 (38) 21 (33) 18 (29)
Physical exercise
Newborn – 3 yrs 8 (62) 0 (0) 5 (38)
4–10 years 11 (85) 2 (16) 0 (0)
11–18 years 10 (77) 2 (15) 1 (8)
Adult 57 (89) 5 (8) 2 (3)
Positioning
Newborn – 3 yrs 10 (72) 1 (8) 3 (22)
4–10 years 6 (46) 5 (38) 2 (16)
11–18 years 5 (38) 6 (46) 2 (15)
Adult 54 (84) 5 (8) 5 (8)
Sustained maximal inspiration
Newborn – 3 yrs NA NA NA
4–10 years NA NA NA
11–18 years NA NA NA
Adult 19 (30) 12 (19) 33 (51)
NA Not asked
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Active cycle of breathing technique
Adult 58 (90) 5 (8) 1 (2)
Paediatric 12 (92) 1 (8) 0 (0)
Autogenic Drainage
Adult 49 (76) 14 (22) 1 (2)
Paediatric 10 (78) 2 (15) 1 (8)
Deep breathing exercises
Adult 34 (53) 24 (38) 6 (9)
Paediatric 8 (61) 5 (38) 0 (0)
Directed huffing (Forced Expiration Technique)
Adult 61 (95) 3 (5) 0 (0)
Paediatric 12 (100) 0 (0) 0 (0)
Postural Drainage (Head Down Tilt)
Adult 22 (35) 27 (42) 15 (23)
Paediatric 2 (15) 4 (31) 7 (54)
Modified Postural Drainage (no Head Down Tilt)
Adult 46 (72) 11 (17) 7 (11)
Paediatric 7 (54) 5 (39) 1 (8)
Manual vibration
Adult 46 (74) 12 (20) 4 (6)
Paediatric 11 (85) 2 (15) 0 (0)
Mechanical vibration
Adult 9 (14) 42 (68) 12 (18)
Paediatric 3 (23) 8 (63) 2 (14)
Oscillating Positive Expiratory Pressure device
Adult 62 (97) 2 (3) 0 (0)
Paediatric 12 (92) 1 (8) 0 (0)
Oscillating Positive Expiratory Pressure bubble/bottle
Adult 53 (83) 10 (15) 1 (2)
Paediatric 11 (85) 1 (8) 1 (8)
Positive Expiratory Pressure mask or mouthpiece
Adult 58 (90) 6 (10) 0 (0)
Paediatric 12 (92) 1 (8) 0 (0)
Percussion
Adult 44 (69) 17 (26) 3 (5)
Paediatric 13 (100) 0 (0) 0 (0)
Physical exercise
Adult 64 (100) 0 (0) 0 (0)
Paediatric 12 (92) 1 (8) 0 (0)
Positioning
Adult 54 (86) 7 (11) 2 (3)
Paediatric 8 (67) 4 (33) 0 (0)
Sustained maximal inspiration
Adult 21 (34) 30 (48) 11 (18)
Paediatric NA NA NA
NA Not asked
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bronchiectasis, but is a growing area of research in cystic
fibrosis [22, 23]. With a high frequency of use of this
ACT in adults and paediatrics, this may be an important
area for future research.
Participants in this study also reported greater use of
PEP and oscillating PEP devices when compared to a pre-
vious study from the United Kingdom in 2002 [11]. In the
previous study [11] PEP was used routinely by 7% of
participants and oscillating PEP by 12% of participants, in
the current study 41% of participants were using PEP
therapy routinely and 75% of participants were using an
oscillating PEP device routinely. This difference may be
due to an increase in availability of these devices, patient
preference to complete ACTs independently, and an
increase in evidence for the safety and efficacy of these
devices in individuals with stable bronchiectasis [12, 24].
Interestingly, oscillating PEP was perceived very effective
or effective by 97% of participants in this study, however
there is little evidence available for the use of oscillating
PEP for individuals with an exacerbation of bronchiectasis.
There have been two small studies [25, 26] which found
that oscillating PEP therapy was preferred by participants
over other types of ACTs. While this may be associated
with increased sputum production during a treatment
session, this result was not significant in either study
[25, 26]. A recent international guideline also recom-
mended implementation of the ACBT or oscillating
PEP for individuals with bronchiectasis [6]. As indi-
viduals with bronchiectasis appear to prefer oscillating
PEP therapy, and most participants in this study per-
ceived this to be an effective ACT, future research
could explore the effect of oscillating PEP therapy,
compared to the ACBT, for individuals with an ex-
acerbation of bronchiectasis.
Another change in ACT prescription is the use of
postural drainage. A previous survey study from 2002 [11]
demonstrated that most participants used postural drain-
age routinely, while participants in this survey reported
rarely using postural drainage incorporating a head down
tilt in the adult population. This shift may reflect the
finding of increased episodes of reflux in cystic fibrosis,
with other treatment techniques taking preference [27].
Another potential explanation is that the recommenda-
tions for ACTs now promote active involvement of the
patient, rather than passive techniques [28].
The ACTs listed in the survey were based on previous
surveys from the United Kingdom and Australia and
New Zealand [11, 14, 15] and show a preference to
ACTs which are more frequently used in this part of the
world. Although participants were given the option of an
open, ‘other’, question to capture information from
participants who used ACTs that were not listed, no
participants in this study listed other ACTs used more
frequently in other parts of the world, such as expiration
with an open glottis in the lateral posture (ETGOL).
This ACT has been shown to be effective to facilitate
secretion removal, reduce exacerbations and improve
quality of life for individuals with bronchiectasis, and so
should be included in future surveys investigating
current practice [29].
The ACTs used by participants serving a paediatric
population varied according to age group. Adherence to
ACTs can be a major problem for children and adoles-
cents with bronchiectasis, and so ensuring techniques are











Patient clinical presentation e.g. sputum amount enquiries 48 (72) 16 (24) 3 (4) 0 (0) 0 (0)
Amount of oxygen/ventilatory support the patient is requiring 38 (57) 23 (34) 3 (4) 3 (4) 0 (0)
Presence/absence of precautions/contra-indications 48 (72) 15 (22) 3 (4) 1 (2) 0 (0)
Patient preference 33 (49) 29 (44) 5 (7) 0 (0) 0 (0)
Patients degree of dyspnoea or work of breathing 37 (55) 26 (39) 4 (6) 0 (0) 0 (0)
Personal experience/preference 14 (21) 30 (45) 17 (25) 4 (6) 2 (3)
Medical staff’s preference 0 (0) 8 (12) 19 (28) 23 (34) 17 (25)
Department/hospital policy 6 (10) 12 (18) 20 (30) 21 (32) 5 (8)
Highest level of evidence supporting a particular airway
clearance technique
23 (34) 29 (43) 12 (18) 3 (5) 0 (0)
Influence from peers with experience in this area 7 (10) 30 (46) 19 (28) 7 (10) 4 (6)
Access to resources/equipment 23 (34) 32 (48) 12 (18) 0 (0) 0 (0)
Recent course attendance 5 (7) 14 (21) 21 (31) 17 (25) 9 (13)
Cost effectiveness 16 (24) 27 (40) 21 (31) 3 (5) 0 (0)
Time effectiveness 17 (25) 29 (43) 18 (27) 3 (5) 0 (0)
Taught at university 1 (2) 7 (10) 11 (17) 16 (25) 31 (46)
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age appropriate is important [17, 30]. In the newborn-3
years age range, techniques used were passive techniques,
appropriate for this age [17]. Regarding management of
individuals aged 4–17 years, participants reported the
common use of directed huffing, physical exercise, PEP
therapy and the ACBT. This contrasts with a previous
survey of New Zealand children and their families with
bronchiectasis [14], with families reporting using PD
(modified or including head down tilt), ACBT or PEP
therapy. The difference in ACT choice between studies
may be due to local practice, therapist’s preference, or the
availability of devices. The previous study was based in
one hospital district, while the current study included
participants from multiple locations across Australia and
New Zealand; this may account for variation in clinical
practice. Additionally, the reports of physiotherapists
managing individuals with bronchiectasis may vary from
the reports of children and their families living with
bronchiectasis.
The most important factors influencing ACT choice
include clinical presentation and presence of contra-
indications. This mirrors what has been reported by phys-
iotherapists managing acute exacerbations of COPD [16].
The least important factors for choice of ACT were simi-
lar to a previous report, being medical staff preference and
training [11]. This implies that physiotherapists are using
assessment and clinical reasoning skills when deciding
which ACT to prescribe. The importance of implementing
techniques that are evidence based has been highlighted
in the clinical guidelines for bronchiectasis (6,7), yet phys-
iotherapists who completed this survey are routinely
using, and perceive effective ACTs underpinned by min-
imal evidence. In the absence of high-quality research,
physiotherapists must rely on other factors when deciding
which ACT to use for a particular patient. It appears, that
participants’ choice of ACT is impacted by access to
resources, perceived time and cost effectiveness of an
ACT and personal experience.
There are limitations to this study. The first is the low
or unknown response rate due to the method of survey
distribution. The number of physiotherapists who re-
ceived the invitation to participate and met the eligibility
criteria is unknown. However, the final number of
responses received (121) was very similar to the raw
numbers achieved in previous surveys of Australian and
New Zealand physiotherapists working with individuals
with chronic respiratory conditions [15, 16]. Further-
more, a previous study investigating ACTs services for
individuals in Australia reported 184 services available,
which is similar to the final number of responses re-
ceived, however it is unable to be determined how many
different services are represented in this study [31]. The
survey remained open for 8 months to maximise partici-
pation numbers, however, this may have influenced the
data collected, as clinical practice may have changed
over time. Approximately 40% of participants had less
than 5 years of respiratory experience. Clinical experi-
ence and exposure are likely to influence practice, and
this may account for the selection of ACTs, perceptions
of efficacy, and factors influencing treatment decisions.
The response numbers to the paediatric section were
lower than for the adult population, which may be due
to a smaller proportion of physiotherapists working with
this population, or, the survey length, with incomplete
responses to questions increasing as participants pro-
gressed through the survey. Although there were partici-
pants across Australia and New Zealand, and a similar
number of responses compared to previous studies com-
pleted in respiratory conditions, it is unknown if the data
accurately represents current practice throughout these
countries. Additionally, the data is self-reported and pre-
dominantly based on multiple choice questions and
Likert scales of perceived use and effectiveness. It is well
documented that clinical reasoning and decision-making
regarding treatment interventions are complex processes
[32, 33], so this is difficult to measure in survey form,
therefore some complexities of participants’ actual clin-
ical practice may not have been identified. No timeframe
for participants to consider when answering each question
was included, and this should be considered in future
surveys. Data regarding inpatient versus outpatient
management are unable to be compared. It is reasonable
to believe that practices may differ between inpatient and
outpatient settings and this should be considered in future
surveys.
Conclusions
Most participants working with adults and all participants
working in paediatrics reported they prescribed ACTs 81–
100% of the time when managing an individual with an
acute exacerbation of bronchiectasis. The most commonly
used ACTs with adults were directed huffing, physical ex-
ercise, the ACBT, positioning and oscillating PEP devices.
Within paediatric populations, the most used ACT varied
depending on age group. All participants believed that di-
rected huffing, physical exercise, oscillating PEP devices,
the ACBT and PEP therapy were effective. Patient clinical
presentation was the most commonly reported important
factor for determining choice of ACT. The findings from
this survey will assist in guiding future research regarding
the clinical efficacy of ACTs for adults and paediatrics
with an acute exacerbation of bronchiectasis.
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